2016


To access this material please log in or register

Register Authorize
2016/№2

Optimization of therapy for chronic heart failure: role of co-enzyme Q10

Zakharova N. A., Martsevich S. Yu.
Federal State Budgetary Institution, “National Research Center for Preventive Medicine”
of the RF Ministry of Health Care, Petroverigsky Per. 10, Bldg. 3, Moscow 101990

Keywords: coenzyme Q10, treatment, CHF

DOI: 10.18087/rhfj.2016.2.2203

The review present results of studies focusing on the use of coenzyme Q10 (CoQ10) in patients with severe CHF, which have demonstrated safety, good tolerability and efficacy of this therapy.
  1. Мареев В. Ю., Агеев Ф. Т., Арутюнов Г. П., Коротеев А. В., Мареев Ю. В., Овчинников А. Г. и др. Национальные рекомендации ОССН, РКО и РНМОТ по диагностике и лечению ХСН (четвертый пересмотр). Журнал Сердечная Недостаточность. 2013;14 (7):379–472 [Mareev V. Yu., Ageev F. T., Arutyunov G. P., Koroteev A. V., Mareev Yu. V., Ovchinnikov A. G. i dr. Naczio­nal`ny`e rekomendaczii OSSN, RKO i RNMOT po diagnostike i lecheniyu XSN (chetverty`j peresmotr). Zhurnal Serdechnaya Nedostatochnost`. 2013;14 (7):379–472].
  2. Ibrahim WH, Bhagavan HN, Chopra RK, Chow CK. Dietary coenzyme Q 10 and vitamin E alter the status of these compounds in rat tissues and mitochondria. J Nutr. 2000 Sep;130 (9):2343–8.
  3. Ланкин В. З., Тихазе А. К., Беленков Ю. Н. Антиоксиданты в комплексной терапии атеросклероза: pro et contra. Кардиология. 2004;44 (2):72–81 [Lankin V. Z., Tixaze A. K., Belenkov Yu. N. Antioksidanty` v kompleksnoj terapii ateroskleroza: pro et contra. Kardiologiya. 2004;44 (2):72–81].
  4. Littarru GP. Energy and Defense. Facts and Perspectives on Coenzyme Q 10 in Biology and Medicine. – Rome: Casa Editrice Scientifica Internazionale, 1994. – P14–22.
  5. Kalén A, Appelkvist EL, Dallner G. Age-related changes in the li­pid compositions of rat and human tissues. Lipids. 1989 Jul;24 (7):579–84.
  6. Alehagen U, Johansson P, Björnstedt M, Rosén A, Dahlström U. Cardiovascular mortality and N-terminal-proBNP reduced after combined selenium and coenzyme Q 10 supplementation: a 5‑year prospective randomized double-blind placebo-controlled trial among elderly Swedish citizens. Int J Cardiol. 2013 Sep 1;167 (5):1860–6.
  7. Molyneux SL, Florkowski CM, George PM, Pilbrow AP, Frampton CM, Lever M, Richards AM. Coenzyme Q 10: an independent predictor of mortality in chronic heart failure. J Am Coll Cardiol. 2008 Oct 28;52 (18):1435–41.
  8. McMurray JJ, Dunselman P, Wedel H, Cleland JG, Lindberg M, Hjalmarson A et al. Coenzyme Q 10, rosuvastatin, and clinical outcomes in heart failure: a pre-specified substudy of CORONA (controlled rosuvastatin multinational study in heart failure). J Am Coll Cardiol. 2010 Oct 5;56 (15):1196–204.
  9. McMurray JJ, Dunselman P, Wedel H, Cleland JG, Lindberg M, Hjalmarson A et al. Coenzyme Q 10, rosuvastatin, and clinical outcomes in heart failure: a pre- specified substudy of CORONA (controlled rosuvastatin multinational study in heart failure). J Am Coll Cardiol. 2010 Oct 5;56 (15):1196–204.
  10. Baggio E, Gandini R, Plancher AC, Passeri M, Carmosino G. Italian multicenter study on the safety and efficacy of coenzyme Q 10 as adjunctive therapy in heart failure. CoQ 10 Drug Surveillance Investigators. Mol Aspects Med. 1994;15 Suppl:s287–94.
  11. Morisco C, Trimarco B, Condorelli M. Effect of coenzyme Q 10 therapy in patients with congestive heart failure: a long-term multicenter randomized study. Clin Investig. 1993;71 (8 Suppl): S134–6.
  12. Lampertico M, Comis S. Italian multicenter study on the efficacy and safety of coenzyme Q 10 as adjuvant therapy in heart failure. Clin Investig. 1993;71 (8 Suppl): S129–33.
  13. Khatta M, Alexander BS, Krichten CM, Fisher ML, Freudenberger R, Robinson SW, Gottlieb SS. The effect of coenzyme Q 10 in patients with congestive heart failure. Ann Intern Med. 2000 Apr 18;132 (8):636–40.
  14. Berman M, Erman A, Ben-Gal T, Dvir D, Georghiou GP, Stamler A et al. Coenzyme Q 10 in patients with end-stage heart failure awaiting cardiac transplantation: a randomized, placebo-controlled study. Clin Cardiol. 2004 May;27 (5):295–9.
  15. Mortensen SA, Rosenfeldt F, Kumar A, Dolliner P, Filipiak KJ, Pella D et al. The effect of coenzyme Q 10 on morbidity and mortality in chronic heart failure: results from Q-SYMBIO: a randomized double-blind trial. JACC Heart Fail. 2014 Dec;2 (6):641–9.
  16. Barth J, Schumacher M, Herrmann-Lingen C. Depression as a risk factor for mortality in patients with coronary heart disease: a meta-analysis. Psychosom Med. 2004 Nov-Dec;66 (6):802–13.
  17. Maes M, Mihaylova I, Kubera M, Uytterhoeven M, Vrydags N, Bosmans E. Lower plasma Coenzyme Q 10 in depression: a marker for treatment resistance and chronic fatigue in depression and a risk factor to cardiovascular disorder in that illness. Neuro Endocrinol Lett. 2009;30 (4):462–9.
Zakharova N. A., Martsevich S. Yu. Optimization of therapy for chronic heart failure: role of co-enzyme Q10 . Russian Heart Failure Journal. 2016;17 (2):144–148

To access this material please log in or register

Register Authorize
Ru En